LNAI
Lunai Bioworks Inc. NASDAQ Listed Sep 30, 2025$1.30
Pre-mkt
$1.30
+0.32%
Mkt Cap $5.9M
52w Low $1.21
0.8% of range
52w High $13.28
50d MA $2.22
200d MA $3.61
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
-0.5x
ROE
1273.6%
P/FCF
-2.7x
RSI (14)
14.60
ATR (14)
$0.24
Beta
0.49
50d MA
$2.22
200d MA
$3.61
Avg Volume
46.0K
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
2080 Century Park East · Los Angeles, CA 90067 · US
Data updated apr 25, 2026 7:28pm
· Source: financialmodelingprep.com